Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights

Globally, primary liver cancer (PLC) ranks the most fatal malignancy. Most of the patients are in advanced stage of PLC at the very time they are diagnosed with it, accounting much for its poor prognosis. With the advancement of modern medical research and care system, the main etiology of PLC more...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuran Wang, Bin Zhang, Runqiu Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1467197/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583813631311872
author Xuran Wang
Bin Zhang
Runqiu Jiang
author_facet Xuran Wang
Bin Zhang
Runqiu Jiang
author_sort Xuran Wang
collection DOAJ
description Globally, primary liver cancer (PLC) ranks the most fatal malignancy. Most of the patients are in advanced stage of PLC at the very time they are diagnosed with it, accounting much for its poor prognosis. With the advancement of modern medical research and care system, the main etiology of PLC more and more switches from hepatitis viruses such as HAV, HBV, HCV, HEV to other causes like metabolism-associated steatohepatitis (MASH) and metabolic-associated fatty liver disease (MAFLD). As a result, it is of great necessity to find out new ways for treatment and early diagnosis to cope with this problem. Nowadays, as the mechanism of the Gut-Liver Axis in the formation of MAFLD, MASH and PLC has been gradually elucidated. The association between gut microbiome and the formation of PLC is of great significance to take an insight into. In this review, we present the concept of Gut-Liver Axis and its function in the mutual influence between gut microbiota and PLC from several aspects in which we will focus on the structure of gut barrier and the functional influences the gut microbiota have on the immune response and metabolic changes on human liver. Furthermore, we conclude the potential association of gut microbiota constitution with the PLC. Eventually, we hope this review can offer novel instructions for early diagnosis and treatment for liver cancer.
format Article
id doaj-art-c8b01bef39614b6e95b5303bed6b8086
institution Kabale University
issn 2235-2988
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-c8b01bef39614b6e95b5303bed6b80862025-01-28T06:41:14ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-01-011510.3389/fcimb.2025.14671971467197Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insightsXuran Wang0Bin Zhang1Runqiu Jiang2Medical School of Nanjing University, Nanjing, Jiangsu, ChinaDepartment of Gastroenterology, Affiliated Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaGlobally, primary liver cancer (PLC) ranks the most fatal malignancy. Most of the patients are in advanced stage of PLC at the very time they are diagnosed with it, accounting much for its poor prognosis. With the advancement of modern medical research and care system, the main etiology of PLC more and more switches from hepatitis viruses such as HAV, HBV, HCV, HEV to other causes like metabolism-associated steatohepatitis (MASH) and metabolic-associated fatty liver disease (MAFLD). As a result, it is of great necessity to find out new ways for treatment and early diagnosis to cope with this problem. Nowadays, as the mechanism of the Gut-Liver Axis in the formation of MAFLD, MASH and PLC has been gradually elucidated. The association between gut microbiome and the formation of PLC is of great significance to take an insight into. In this review, we present the concept of Gut-Liver Axis and its function in the mutual influence between gut microbiota and PLC from several aspects in which we will focus on the structure of gut barrier and the functional influences the gut microbiota have on the immune response and metabolic changes on human liver. Furthermore, we conclude the potential association of gut microbiota constitution with the PLC. Eventually, we hope this review can offer novel instructions for early diagnosis and treatment for liver cancer.https://www.frontiersin.org/articles/10.3389/fcimb.2025.1467197/fullHCCgut-liver axisgut microbiomemicrobial metabolitesliver cancer
spellingShingle Xuran Wang
Bin Zhang
Runqiu Jiang
Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
Frontiers in Cellular and Infection Microbiology
HCC
gut-liver axis
gut microbiome
microbial metabolites
liver cancer
title Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
title_full Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
title_fullStr Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
title_full_unstemmed Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
title_short Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
title_sort microbiome interplays in the gut liver axis implications for liver cancer pathogenesis and therapeutic insights
topic HCC
gut-liver axis
gut microbiome
microbial metabolites
liver cancer
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1467197/full
work_keys_str_mv AT xuranwang microbiomeinterplaysinthegutliveraxisimplicationsforlivercancerpathogenesisandtherapeuticinsights
AT binzhang microbiomeinterplaysinthegutliveraxisimplicationsforlivercancerpathogenesisandtherapeuticinsights
AT runqiujiang microbiomeinterplaysinthegutliveraxisimplicationsforlivercancerpathogenesisandtherapeuticinsights